Search
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer
- OPACC
- Apr 9, 2024
- 1 min read
Findings from scientists at St. Jude Children’s Research Hospital and The University of Tennessee Health Science Center suggest T-cell therapy could effectively treat fibrolamellar carcinoma.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Kommentare